Published in Gastrointest Endosc on September 01, 2004
Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol (2015) 2.35
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30
Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol (2008) 1.25
Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol (2011) 1.23
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis (2009) 1.10
Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol (2009) 0.97
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis (2016) 0.93
Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. Inflamm Bowel Dis (2013) 0.90
Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol (2006) 0.90
Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines. Ann Gastroenterol (2012) 0.90
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis (2012) 0.85
Endoscopic and pathological aspects of colitis-associated dysplasia. Nat Rev Gastroenterol Hepatol (2009) 0.83
Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis (2011) 0.82
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am (2014) 0.82
Non-polypoid colorectal neoplasms: Classification, therapy and follow-up. World J Gastroenterol (2015) 0.81
Surveillance programmes for neoplasia in colitis. J Gastroenterol (2010) 0.81
Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol (2014) 0.81
Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis (2014) 0.79
Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis. World J Gastrointest Endosc (2014) 0.78
Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect. Inflamm Bowel Dis (2013) 0.78
Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.78
Colitis-associated colon cancer: Is it in your genes? World J Gastroenterol (2015) 0.77
Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance. Gastrointest Tumors (2014) 0.76
Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer. Gastrointest Cancer Res (2009) 0.76
Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future. Gastroenterol Hepatol (N Y) (2015) 0.75
Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer. Intest Res (2016) 0.75
Inflammatory bowel disease associated neoplasia: A surgeon's perspective. World J Gastroenterol (2016) 0.75
Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance? Clin Gastroenterol Hepatol (2015) 0.75
The world isn't flat. Gastrointest Endosc (2004) 0.75
Endoscopic Therapy in Inflammatory Bowel Diseases. Viszeralmedizin (2015) 0.75
Dysplasia and colitis. Can J Gastroenterol (2009) 0.75
Atypical rectal bleeding: the challenge of diagnosing mild ulcerative colitis. Dig Dis Sci (2010) 0.75
Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection. Dig Dis Sci (2016) 0.75
Endoscopic Surveillance in Long-standing Colitis. Curr Treat Options Gastroenterol (2017) 0.75
Endoscopic Diagnosis and Treatment of Precancerous Colorectal Lesions in Patients with Inflammatory Bowel Disease: How Does the Latest SCENIC International Consensus Intersect with Our Clinical Practice? J Transl Int Med (2017) 0.75
Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75
Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol (2007) 0.75
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med (2004) 6.77
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut (2010) 6.34
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet (2008) 4.96
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology (2004) 4.45
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20
ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr (2009) 4.11
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology (2005) 4.06
Optical diagnosis of small colorectal polyps at routine colonoscopy (Detect InSpect ChAracterise Resect and Discard; DISCARD trial): a prospective cohort study. Lancet Oncol (2009) 3.86
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology (2013) 3.55
A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology (2007) 3.37
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology (2007) 2.97
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet (2005) 2.93
Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology (2003) 2.92
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology (2006) 2.63
Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One (2013) 2.50
Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol (2002) 2.45
Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am J Gastroenterol (2009) 2.39
Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc (2010) 2.38
Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial. Gastrointest Endosc (2010) 2.28
Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology (2005) 2.25
Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis (2011) 2.24
Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol (2012) 2.24
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet (2004) 2.17
Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc (2013) 2.16
Simulator training improves practical skills in therapeutic GI endoscopy: results from a randomized, blinded, controlled study. Gastrointest Endosc (2009) 2.15
Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology (2012) 2.11
Comparison of magnified pit pattern interpretation with narrow band imaging versus chromoendoscopy for diminutive colonic polyps: a pilot study. Gastrointest Endosc (2007) 2.07
Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet (2005) 1.84
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology (2012) 1.83
Myths and misconceptions about chronic constipation. Am J Gastroenterol (2005) 1.78
Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis (2010) 1.78
Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis. Clin Gastroenterol Hepatol (2007) 1.72
A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol (2007) 1.71
Endoscopic mucosal resection of 161 cases of large sessile or flat colorectal polyps. Scand J Gastroenterol (2007) 1.71
Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am (2008) 1.65
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology (2006) 1.64
Obstetric anal sphincter injury: incidence, risk factors, and management. Ann Surg (2008) 1.63
Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut (2010) 1.61
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
Position changes improve visibility during colonoscope withdrawal: a randomized, blinded, crossover trial. Gastrointest Endosc (2006) 1.58
Surface visualization at CT colonography simulated colonoscopy: effect of varying field of view and retrograde view. Am J Gastroenterol (2007) 1.57
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial. BMJ (2012) 1.51
Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc (2002) 1.50
Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol (2006) 1.49
Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol (2006) 1.48
Treatment with argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: a randomized trial and recommendations. Gastrointest Endosc (2002) 1.46
Diagnosing small bowel malabsorption: a review. Intern Emerg Med (2012) 1.45
Multi-detector row CT colonography: effect of collimation, pitch, and orientation on polyp detection in a human colectomy specimen. Radiology (2003) 1.44
Anorexia nervosa in gastrointestinal practice. Eur J Gastroenterol Hepatol (2004) 1.44
Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology (2008) 1.43
Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients. Scand J Gastroenterol (2006) 1.41
Noninvasive imaging of the small bowel in Crohn's disease: the final frontier. Inflamm Bowel Dis (2011) 1.40
Colorectal stenting for malignant and benign disease: outcomes in colorectal stenting. Dis Colon Rectum (2004) 1.37
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet (2003) 1.32
Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis (2011) 1.30
Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology (2006) 1.29
Acceptance by patients of multidetector CT colonography compared with barium enema examinations, flexible sigmoidoscopy, and colonoscopy. AJR Am J Roentgenol (2003) 1.27
Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral Nutr (2010) 1.27
Colonoscopy at a combined district general hospital and specialist endoscopy unit: lessons from 505 consecutive examinations. J R Soc Med (2002) 1.27
A new prognostic staging system for rectal cancer. Ann Surg (2004) 1.26
First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis (2013) 1.25
Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis (2011) 1.24
Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology (2004) 1.24
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis (2011) 1.22
Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol (2012) 1.22
Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet (2010) 1.21
Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol (2003) 1.21
Development and validation of a training module on the use of narrow-band imaging in differentiation of small adenomas from hyperplastic colorectal polyps. Gastrointest Endosc (2011) 1.17
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis (2009) 1.14
Female anal sphincter: age-related differences in asymptomatic volunteers with high-frequency endoanal US. Radiology (2002) 1.13
The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study. Dis Colon Rectum (2010) 1.13
Ghrelin for the gastroenterologist: history and potential. Gastroenterology (2003) 1.12
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis (2006) 1.11
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch. J Crohns Colitis (2013) 1.09
Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol (2005) 1.08
Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet (2002) 1.08
Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation. Am J Gastroenterol (2002) 1.08
Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol (2008) 1.07
Effect of magnetic endoscope imaging on patient tolerance and sedation requirements during colonoscopy: a randomized controlled trial. Gastrointest Endosc (2002) 1.05
Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol (2012) 1.04
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol (2007) 1.03
Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol (2003) 1.03
Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol (2013) 1.03
Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study. Radiology (2009) 1.02